美国 FDA · 官方机构
7月6日 12:00 · 阅读约 1 分钟
美国 FDA· US67分
Determination That VASOPRESSIN IN SODIUM CHLORIDE (vasopressin) 0.9%, Injection, 50 units/50 milliliters (1 unit/milliliters) Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
摘要
The Food and Drug Administration (FDA or Agency) has determined that VASOPRESSIN IN SODIUM CHLORIDE (vasopressin) 0.9%, injection, 50 units/50 milliliters (mL) (1 unit/mL) was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for VASOPRESSIN IN SODIUM CHLORIDE (vasopressin) 0.9%, injection, 50 units/ 50 mL (1 unit/mL), if all other legal and regulatory requirements are met.
五维评分
信源权威度
95
影响范围
70
合规紧急度
40
行业关注度
35
时效性
80